Pharmaceuticals - Montenegro

Montenegro

Montenegro is projected to see a substantial growth in revenue within the Pharmaceuticals market.
By 2024, the projected revenue is expected to reach US$45.49m.
Among the various markets, the largest share is expected to be held by Oncology Drugs, with a projected market volume of US$8.78m by 2024.
Looking ahead to the period between 2024 and 2028, it is anticipated that the revenue will experience an annual growth rate of 6.63%, resulting in a market volume of US$58.80m by 2028.
When compared globally, it is noteworthy that United States is expected to generate the highest revenue within the Pharmaceuticals market, amounting to US$636.90bn in 2024.
Montenegro's pharmaceutical market is experiencing a surge in demand for innovative medicines and a shift towards personalized healthcare solutions.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Montenegro has been experiencing a steady growth in recent years.

Customer preferences: Montenegro's population is aging, leading to an increase in demand for pharmaceutical products. Additionally, the country has a high prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer, which require long-term treatment and medication.

Trends in the market: The pharmaceutical industry in Montenegro is dominated by multinational companies, which account for the majority of the market share. However, there has been a recent trend towards the development of domestic pharmaceutical companies, which are focusing on the production of generic drugs. This is due to the government's efforts to reduce healthcare costs by promoting the use of cheaper generic drugs.

Local special circumstances: Montenegro's healthcare system is undergoing significant reforms, aimed at improving the quality of care and reducing costs. As part of these reforms, the government has introduced a new system for the reimbursement of drugs, which is expected to increase the affordability of pharmaceutical products for patients. Additionally, the government is investing in the development of the country's healthcare infrastructure, which is expected to boost the demand for pharmaceutical products.

Underlying macroeconomic factors: Montenegro's economy is heavily dependent on tourism, which has been negatively impacted by the COVID-19 pandemic. However, the pharmaceutical industry has remained resilient, as demand for healthcare products has increased due to the pandemic. Additionally, the country's accession to the European Union is expected to provide new opportunities for the pharmaceutical industry, as it will allow for easier access to the EU market and increased investment in the sector.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.